Bluejay Diagnostics, Inc. (BJDX) Analyst Estimates Annual - Discounting Cash Flows
BJDX
Bluejay Diagnostics, Inc.
BJDX (NASDAQ)
Period Ending: 2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2022
12-30
Number of Analysts 1 1 1 1 0 None
Estimated Revenue
Low 32.65 18.48 7.86 5.05 0 0.249
Average 32.65 18.48 7.86 5.05 0 0.249
High 32.65 18.48 7.86 5.05 0 0.249
Estimated EBITDA
Low 19.59 11.09 4.72 3.03 0 0.149
Average 19.59 11.09 4.72 3.03 0 0.149
High 19.59 11.09 4.72 3.03 0 0.149
Estimated EBIT
Low 19.59 11.09 4.72 3.03 0 0.149
Average 19.59 11.09 4.72 3.03 0 0.149
High 19.59 11.09 4.72 3.03 0 0.149
Estimated Net Income
Low 18.34 -1.47 -21.27 -23.47 -72.62 -440.1
Average 18.34 -1.47 -21.27 -23.47 -72.62 -440.1
High 18.34 -1.47 -21.27 -23.47 -72.62 -440.1
Estimated SGA Expenses
Low 162.9 92.16 39.21 25.21 0 1.24
Average 162.9 92.16 39.21 25.21 0 1.24
High 162.9 92.16 39.21 25.21 0 1.24
Estimated EPS
Low 400 -32 -464 -512 -1,584 -2,400
Average 400 -32 -464 -512 -1,584 -2,400
High 400 -32 -464 -512 -1,584 -2,400
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program